RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Iperinsulinismo congenito dell'infanzia: valutazione clinica e metabolica; analisi genetica e correlazione fenotipica; creazione registro nazionale.
• 2 - Parkinson e parkinsonismi: epidemiologia, basi molecolari, modelli diagnostici e farmacogenetica
• 3 - Paraparesi spastiche ereditarie: studio genetico, funzionale, clinico
• 4 - Aspetti biochimici e genetici del disturbo autistico.
• 5 - DISSEZIONE DEI FATTORI GENETICI E COMPRENSIONE DEI MECCANISMI RESPONSABILI DEL DIABETE AUTOIMMUNE
• 6 - STUDI SUI FATTORI GENETICI ED IMMUNOLOGICI CHE REGOLANO IL DANNO TESSUTALE ED IL DECORSO CLINICO DELL'ARTRITE REUMATOIDE
• 7 - Nuove acquisizioni sul carico mutazionale e sulle possibilità di monitoraggio citogenetico e molecolare delle displasie/neoplasie mieloidi
• 8 - Genetica, biologia e clinica dei paragangliomi: le mutazioni della succinodeidrogenasi mitocondriale come modello di studio della trasmissione, crescita, variabilità e trattamento dei tumori di derivazione dalla cresta neurale
• 9 - Studio dei meccanismi molecolari alla base dell’anomala proliferazione e funzione paratiroidea, e identificazione ed uso clinico di marcatori molecolari di carcinoma paratiroideo sporadico e familiare. Nuove acquisizione sulla prevalenza delle manifestazioni scheletriche, neuropsichiche e metaboliche dell’iperparatiroidismo primario, loro relazione con i polimorfismi del recettore del calcio ed effetti della paratiroidectomia.
• 10 - Meccanismi di controllo dell’eritropoiesi e policitemie congenite e familiari: ruolo delle vie di risposta alla pressione di ossigeno

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • GENETICA MEDICA
  • NEUROLOGIA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

Classificazione geografica

• Regione: Toscana

Bibliografia

Andersen PM, Sims KB, Xin WW et al. (2003). Sixteen novel mutations in the gene encoding CuZn-superoxide dismutase in ALS. Amyotrop Lateral Scler Other Motor Neuron Disord. 2:62–73.

Andersen PM, Borasio GD, Dengler R, Hardiman O, Kollewe K, Leigh PN, Pradat PF, Silani V and Tomik B. (2005) EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives An evidence-based review with good practice points. European Journal of Neurology. 12: 921–938.

Andersen PM. (2006) Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr Neurol Neurosci Rep. Jan;6(1):37-46. Review.
Armon C and Brandstater ME. (1999). Motor unit number estimate-based rates of progression of ALS predict patient survival. Muscle Nerve. 22, 1571-75.

Battistini S, Giannini F, Greco G, Bibbo G, Ferrera L, Marini V, Causarano R, Casula M, Lando G, Patrosso MC, Caponnetto C, Origone P, Marocchi A, Del Corona A, Siciliano G, Carrera P, Mascia V, Giagheddu M, Carcassi C, Orru S, Garre C, Penco S. (2005) SOD1 mutations in amyotrophic lateral sclerosis Results from a multicenter Italian study. J Neurol, published online: 29 March 2005.

Brockington A, Kirby J, Eggitt D, Schofield E, Morris C, Lewis CE, Ince PG, Shaw PJ. (2005) Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosis. Neurogenetics.6(2):101-4.

Brown RH. (1998) SOD1 aggregates in ALS: cause, correlate or consequence? Nat Med 4:1362 1364.

Daube JR. (1999). Motor unit estimates in ALS. In Kimura J, Kaji R (eds.) Physiology of ALS and related diseases, Amsterdam: Elsevier Science, pp. 203-16.

Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL. (1985 ) Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry. Sep 24;24(20):5480-6.

Greenway MJ, Alexander MD, Ennis S, Traynor BJ, Corr B, Frost E, Green A, Hardiman O. (2004) A novel candidate region for ALS on chromosome 14q11.2. Neurology. Nov 23;63(10):1936-37.

Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, Patterson V, Swingler R, Kieran D, Prehn J, Morrison KE, Green A, Acharya KR, Brown RH, Hardiman O. (2006) ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet. Apr;38(4):411-3. Epub 2006 Feb 26.

Hansen S and Ballantyne JP. (1978). A quantitative electrophysiological study of motor neuron disease. J Neurol Neurosurg Psychiatry. 41, 773-83.

Hu GF, Riordan JF, Vallee BL. (1997) Related Articles, Links. A putative angiogenin receptor in angiogenin-responsive human endothelial cells. Proc Natl Acad Sci U S A. Mar 18;94(6):2204-9.
Kishimoto K, Liu S, Tsuji T, Olson KA, Hu GF. (2005) Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene. Jan 13;24(3):445-56.

Kunst CB.(2004) Complex genetics of amyotrophic lateral sclerosis. Am J Hum Genet. Dec;75(6):933-47 Review.

Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, et al. (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death.
Nat Genet. Aug;34(4):383-94.

Matsuzaki H, Tamatani M, Yamaguchi A, Namikawa K, Kiyama H, et al. (2001) Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. FASEB J. 15:1218-1220.

McComas AJ, Fawcett PRW, Campbell MJ & Sica RE. (1971). Electrophysiological estimation of the number of motor units within a human muscle. J Neurol Neurosurg Psychiatry. 34, 121-31.

Moreau C, Devos D, Brunaud-Danel V, Defebvre L, Perez T, Destée A, Tonnel AB, Lassalle Ph, Just N. (2006) Paradoxical respons eof VEGF expression to hypoxia in CSF of patients with ALS. J Neurol Neurosurg Psychiatry 77:255-257.

Oosthuyse B, Moons L, Storkebaum E, et al. (2001) Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet. 28(2):131-8.

Popovici C, Isnardon D, Birnbaum D, Robuin R (2002). Caenorhabditis elegans receptors related to mammalian vascular endothelial growth factor receptor are expressed in neural cells. Neurosci Lett. 329:116-120.

Sartucci F, Maritato P, Moscato G, Orlandi G, Calabrese R, Domenici L, Murri L.(2006). Motor unit number estimation (MUNE) as a quantitative measure of disease progression and motor unit reorganization in amyotrophic lateral sclerosis. Inter J Neurosci (in press).

Shapiro R, Fox EA, Riordan JF. (1989) Role of lysines in human angiogenin: chemical modification and site-directed mutagenesis. Biochemistry. Feb 21;28(4):1726-32.

Shapiro R, Vallee BL. (1989) Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis. Biochemistry. Sep 5;28(18):7401-8.

Shefner JM. (2001). Motor unit number estimation in human neurological diseases and animal models. Clin Neurophysiol. 112, 955-64.

Sondell M, Sundler F, Kajn M. (2000) Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosi. 90:1529-1541.

Van Vught PWJ, Sutedja NA, Veldink JH, Koeleman BPC, Groeneveld GJ, Wijmenga C, Uitdehaag, BMJ, de Jong JMBV, Baas F, Wokke JHJ, Van den Berg LH (2005) Lack of association between VEGF polymorphisms and ALS in a Dutch population. Neurology 65:1643-1645.

Vande Velde C, Cleveland DW. (2005) VEGF: multitasking in ALS. Nat Neurosci. 8(1):5-7.

Zheng C, Nennesmo I, Fadeel B, Henter JI. (2004) Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann Neurol. 56 :564-7.

Parole Chiave

SCLEROSI LATERALE AMIOTROFICA, GENE VEGF, GENE ANGIOGENINA, GENI DI SUSCETTIBILITA', STUDI DI ASSOCIAZIONE, NEUROPROTEZIONE, STIMA DEL NUMERO UNITA' MOTORIE (MUNE), VELOCITA' DI PROGRESSIONE DI MALATTIA, CORRELAZIONE GENOTIPO-FENOTIPO